» Articles » PMID: 7564500

A New Myeloproliferative Disorder Associated with Chromosomal Translocations Involving 8p11: a Review

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 1995 Oct 1
PMID 7564500
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosomal breakpoints associated with malignancy are known to cluster at particular regions of the karyotype. Based on a review of the literature we have identified a novel leukaemia syndrome associated with translocations involving 8p11. This syndrome is distinct from the previously described translocation t(8;16)(p11;p13) associated with acute monoblastic leukaemia. We have summarized the clinical and cytogenetic features of 13 case reports which describe a myeloproliferative syndrome with eosinophilia, lymphadenopathy and a high incidence of T cell non-Hodgkin's lymphoma with progression to acute myeloid leukaemia. The translocations involving 8p11 were: either t(8;13)(p11-12;q11-12), t(8;9) (p11;q32-34) or t(6;8)(q27;p12). In two cases of t(8;13) molecular studies have mapped the chromosome 13 breakpoint to a 1.5 Mbp region, but a full molecular characterization of these translocations is required. In view of the striking clinicopathological and karyotypic similarities between these cases we propose that they be considered a single nosological entity and termed '8p11 myeloproliferative syndrome'.

Citing Articles

Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review.

Guo Y, Ma M, Tian T, Zhang J, Guo X, Qiao S Oncol Lett. 2024; 28(4):468.

PMID: 39119236 PMC: 11306990. DOI: 10.3892/ol.2024.14601.


Hematological Neoplasms with Eosinophilia.

Morales-Camacho R, Caballero-Velazquez T, Borrero J, Bernal R, Prats-Martin C Cancers (Basel). 2024; 16(2).

PMID: 38254826 PMC: 10814743. DOI: 10.3390/cancers16020337.


Myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement in Vietnam: a case report and literature review.

Chu T, Huynh T, Nguyen K, Phu C Hematol Transfus Cell Ther. 2023; 46(4):498-502.

PMID: 37316385 PMC: 11451361. DOI: 10.1016/j.htct.2023.04.002.


Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasms.

Gotlib J Hematology Am Soc Hematol Educ Program. 2022; 2022(1):34-46.

PMID: 36485158 PMC: 9821059. DOI: 10.1182/hematology.2022000368.


Myeloproliferative Syndrome With Eosinophilia Associated With Translocation t(8; 13) and T-cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature.

Urrea Pineda L, Perilla O, Santiago-Pacheco V, Trujillo Montoya S Cureus. 2022; 14(3):e22734.

PMID: 35386486 PMC: 8969320. DOI: 10.7759/cureus.22734.